Enzymatica appoints Acting CFO during transition period

Kristina Rylander has, for an extended period, served as a consultant to Enzymatica, which has provided her with insight into the company’s operations and processes. In her role as Acting CFO, she will ensure continuity in Enzymatica’s financial reporting, internal processes, and ongoing projects.

“We are very pleased to welcome Kristina Rylander as Acting CFO. Her solid expertise, extensive experience, and familiarity with Enzymatica provide us with excellent conditions for a smooth transition period,” says Claus Egstrand, CEO of Enzymatica.

Datum 2025-12-11, kl 12:00
Källa Cision
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!